36 Stocks Moving In Tuesday's Mid-Day Session



  • Pasithea Therapeutics Corp. KTTA shares jumped 216.6% to $7.00 after the company announced its subsidiary Pasithea Clinics has been approved to provide esketamine nasal spray for the treatment of resistant depression in adults.
  • Petros Pharmaceuticals, Inc. PTPI climbed 101.5% to $2.68. The company filed proxy statement for annual meeting after the market close on Monday.
  • iSpecimen Inc. ISPC gained 58.1% to $14.04. iSpecimen shares jumped over 80% on Monday after the company announced it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments.
  • Qualigen Therapeutics, Inc. QLGN jumped 49.6% to $1.87 after a Zack's Small Cap research note showed a $9 price target on the stock.
  • Gracell Biotechnologies Inc. GRCL gained 44.2 to $9.20. Gracell Biotech said members of its senior mgmt. team, including, Chair, CEO, CFO, Chief Medical Officer intend to use personal funds to buy up to $2 million in company’s ADSs in open market over next 3 months.
  • Aptevo Therapeutics Inc. APVO shares climbed 42.4% to $9.23 after the company announced a clinical update for its Phase 1b Expansion trial evaluating APVO436 for acute myeloid leukemia (AML).
  • Sunlands Technology Group STG gained 27.8% to $4.68 after reporting unaudited Q3 results.
  • Dycom Industries, Inc. DY surged 17.5% to $98.15 following upbeat Q3 results.
  • XL Fleet Corp. XL gained 16.9% to $5.43 after the company announced it was awarded a pilot project with the Department of Defense to prototype fuel-saving technology for tactical vehicles.
  • MediciNova, Inc. MNOV jumped 13% to $3.47. Zacks Small-Cap Research set $27 valuation on MediciNova.
  • Tonix Pharmaceuticals Holding Corp. TNXP shares rose 10.4% to $0.5139. The FDA has signed off Tonix Pharmaceuticals’ Investigational New Drug (IND) Application to initiate Phase 2 study of TNX-1900 for migraine.
  • Kosmos Energy Ltd. KOS gained 9.7% to $3.7350.
  • XPeng Inc. XPEV jumped 9.5% to $51.88. XPeng reported third-quarter revenues that exceeded expectations but the loss per share trailed expectations. The company's gross margins expanded both sequentially and year-over-year.
  • Movado Group, Inc. MOV gained 9.1% to $43.55 following Q3 results.
  • Soligenix, Inc. SNGX rose 8.3% to $0.8991. Soligenix recently posted a Q3 loss of $0.09 per share.
  • RLX Technology Inc. RLX rose 8.2% to $5.31 after climbing 9% on Monday.
  • Burlington Stores, Inc. BURL surged 8.1% to $284.22 after the company reported better-than-expected Q3 results.
  • Western Digital Corporation WDC gained 6.6% to $60.71. Mizuho analyst Vijay Rakesh upgraded Western Digital to Buy from Neutral with a price target of $75, up from $55, implying a 31.7% upside.

Check out these big penny stock gainers and losers


  • Longeveron Inc. LGVN shares fell 29.9% to $19.77. The company last week announced the FDA granted Rare Pediatric Disease designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome.
  • Greenland Technologies Holding Corporation GTEC fell 23.7% to $8.92. Greenland Technologies will present at the upcoming Sequire Cleantech & Electric Vehicle Investor Conference to be held virtually on December 6, 2021.
  • Society Pass Incorporated SOPA fell 23% to $30.00. The company, earlier during the month, priced its IPO at $9 per share.
  • Aurora Innovation, Inc. AUR dipped 18% to $12.25.
  • Zoom Video Communications, Inc. ZM fell 17.2% to $200.66. Zoom Video reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. B of A Securities downgraded Zoom from Buy to Neutral and lowered the price target from $385 to $270.
  • Best Buy Co., Inc. BBY fell 16.3% to $115.53 after the company reported third-quarter FY22 Enterprise sales growth of 0.5% year-on-year, to $11.91 billion, beating the analyst consensus of $11.56 billion. Enterprise comparable sales increased 1.6% versus 23.0% growth last year.
  • Abercrombie & Fitch Co. ANF declined 16% to $39.56 after the company reported Q3 earnings results.
  • Vinco Ventures, Inc. BBIG dropped 15.9% to $3.28. Vinco Ventures reported a third-quarter FY21 sales decline of 11.5% year-on-year, to $2.23 million.
  • Genius Sports Limited GENI dipped 14.5% to $11.66 after the company reported better-than-expected Q3 sales results and raised FY21 sales guidance above estimates.
  • Relay Therapeutics, Inc. RLAY dropped 13.5% to $29.63
  • PainReform Ltd. PRFX fell 11.7% to $2.03. PainReform recently posted a net loss of $5.5 million during the nine months ended Sept. 30, 2021.
  • Urban Outfitters, Inc. URBN fell 11% to $33.19. Urban Outfitters posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter.
  • Oramed Pharmaceuticals Inc. ORMP shares fell 9.2% to $17.20 after declining 28% on Monday. Oramed Pharmaceuticals said it has enrolled and randomized over 75% of the 675 patients planned for its Phase 3 ORA-D-013-1 study of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes.
  • DICK'S Sporting Goods, Inc. DKS declined 9.1% to $127.49 following Q3 results.
  • Central Garden & Pet Company CENTA dropped 9.1% to $45.22 following Q4 results.
  • The Lovesac Company LOVE fell 8.7% to $73.93. Andrew R Heyer, Insider at Lovesac, made a large insider sell on November 19, according to a new SEC filing.
  • Adamis Pharmaceuticals Corporation ADMP fell 8% to $0.8101. Adamis Pharmaceuticals said sales for the nine months ended Sept. 30, 2021 came in at $3.4 million.
  • Hibbett, Inc. HIBB dropped 7.9% to $91.81. Hibbett is expected to issue its Q3 earnings release before the market opens on December 3, 2021.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!